![Clarapath and Mayo Clinic modernize their pathology labs with robotics, AI and automation](https://hitconsultant.net/wp-content/uploads/2024/04/Clarapath-and-Mayo-Clinic-Modernize-Pathology-Labs-with-Robotics-AI-Automation.png)
What you should know:
– Clarapatha medical robotics company whose mission is to transform tissue processing in pathology laboratories, announced a strategic collaboration with Mayo Clinic, a world-renowned leader in medical care and research.
– The strategic partnership marks an important step towards a new era of automation and efficiency within pathology laboratories.
The challenge: manual processes and growing demands
For decades, pathology laboratories have relied on manual and labor-intensive procedures to process tissue samples critical to diagnosing diseases like cancer. However, these traditional methods face several challenges:
- Labor shortages: The healthcare sector is facing a growing shortage of qualified personnel, putting a strain on laboratory capacity.
- Quality control issues: Manual processes are inherently prone to human error, which can impact diagnostic accuracy.
- Increase in sample volume: The ever-increasing volume of samples is straining the resources of existing laboratories.
SectionStar™ from Clarapath: a robotic solution
Clarapath’s innovative SectionStar™ system addresses these challenges head on. This automated system uses robotics, artificial intelligence (AI)and integrated pathology workflows to:
- Standardize slide production: SectionStar™ ensures consistent, high-quality slide preparation, minimizing human errors.
- Reduce processing time: Automation significantly speeds up sample processing times, improving laboratory efficiency.
- Minimize human intervention: The system reduces the need for manual tasks, freeing up laboratory staff for other critical activities.
Collaboration for global impact
This strategic collaboration brings together Clarapath’s cutting-edge technology and Mayo Clinic’s deep clinical expertise. This combined effort aims to:
- Transform histology labs around the world: The partnership will facilitate global adoption of digital pathology solutions, leading to significant improvements in quality, safety, cost and throughput within histology laboratories.
- Improved patient care: Faster turnaround times and improved quality control result in more informed and faster diagnoses, ultimately benefiting the delivery of patient care.
- Future innovations: The collaboration paves the way for the development of next-generation solutions to further optimize histopathology workflows.
Strengthening expertise: Dr. García joins the Clarapath board of directors
As part of this collaboration, Dr. Joaquín García, a leading figure in digital pathology at Mayo Clinic, will join Clarapath's board of directors. His expertise will be invaluable in guiding the development and implementation of innovative technologies for the future of pathology laboratories.
“We are excited to collaborate with Mayo Clinic to advance the modernization of anatomic pathology,” said Eric Feinstein, CEO of Clarapath. “Laboratories, like manufacturing plants, need constant innovation and modernization. With SectionStar, leaders can now reinvent the histology process to address increasing caseloads and declining staff numbers. This will help patients get faster test results and more immediate access to care.